Invention Grant
- Patent Title: Heterodimerizing Ig domains
-
Application No.: US16615536Application Date: 2018-06-01
-
Publication No.: US11851489B2Publication Date: 2023-12-26
- Inventor: Fabian Richter , Oliver Seifert , Roland Kontermann
- Applicant: UNIVERSITÄT STUTTGART
- Applicant Address: DE Stuttgart
- Assignee: UNIVERSITÄT STUTTGART
- Current Assignee: UNIVERSITÄT STUTTGART
- Current Assignee Address: DE Stuttgart
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP 174087 2017.06.01
- International Application: PCT/EP2018/064538 2018.06.01
- International Announcement: WO2018/220216A 2018.12.06
- Date entered country: 2019-11-21
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; C07K16/32 ; C07K16/40 ; A61K38/00

Abstract:
The present invention provides a protein complex comprising heterodimerizing regions HRI and HRII, each comprised of antiparallel β-strands and intervening regions wherein HRI and HRII are each interspersed fusion proteins of two human constant regions of an immunoglobulin or immunoglobulin-like proteins. The present invention also provides nucleic acid molecules comprising a sequence encoding said protein complexes and vectors comprising the nucleic acid. The present invention also provides the protein complex, the nucleic acid and the vector for use as a medicament. The present invention further provides a method of determining the amino acid sequence of HRI and/or of the amino acid sequence of HRII. The present invention also provides a method of producing amino acid chains of HRI and/or amino acid chains of HRII. The present invention further provides the protein complex for use in the N prophylaxis, treatment or diagnosis of a disorder or a disease.
Public/Granted literature
- US20200172619A1 HETERODIMERIZING IG DOMAINS Public/Granted day:2020-06-04
Information query